Font Size: a A A
Keyword [Huntington's disease]
Result: 21 - 40 | Page: 2 of 3
21. Herp Promotes Proteasomal Degradation Of Mutated Huntingtin Through Enhancing Ubiquitination
22. Mutant Huntingtin Inhibits The Expression Of Synaptic Vesicle Protein 2C And The Transport Of Synaptic Vesicles
23. Application Of Brain Diameter Measurement And CAP Score In The Diagnosis Of Huntington Disease
24. The Heterogeneity Of Astrocytes NDRG2 In Mouse Disease Models
25. Using CRISPR/Cas9 Technology To Establish An In Situ Knock-in Mouse Model Of Huntington's Disease (HD)
26. Clinical Characteristics And Genetic Features Of Patients With Huntington's Disease In China And HTT Haplotype Analysis
27. Effects of depression and demographics on word generation in people with Huntington's disease
28. Calcium channel dysfunction in Huntington's disease
29. Advances in the in vitro study of Huntington's disease mutagenesis and pathogenesis
30. A neuroanatomical analysis of striosome-matrix compartmentalization and motor deficits in YAC mouse models of Huntington's disease
31. The role of glutamate uptake on neuronal activity patterns and ascorbate release in striatum of Huntington's disease mice
32. Viral transfection of mesenchymal stem cells to overexpress brain-derived neurotrophic factor and nerve growth factor as potential therapies for reducing behavioral deficits in the YAC 128 mouse model of Huntington's disease
33. Neuroanatomical correlates of episodic memory in Huntington's disease
34. Neurodevelopmental abnormalities in an animal model of Huntington's disease
35. A proteomic probing of the full-length huntingtin interactome based on a novel BAC transgenic mouse model of Huntington's disease
36. Expression of mutant huntingtin in glial cells contributes to the neuropathology of Huntington's disease
37. Role of p53 in Huntington's disease
38. Depression in children providing care to a parent with Huntington's disease: Caregiving stressors, strains, and the role of social support
39. The Role of Trophic Factors and Other Drugs in the Treatment of Huntington's Disease in R6/2 Mouse Model
40. Serine 421 is a Crucial Mediator of Pathology in a Mouse Model of Huntington's Disease
  <<First  <Prev  Next>  Last>>  Jump to